This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Nov 10;292(18):2211; author reply 2211-2.

doi: 10.1001/jama.292.18.2211-b.

Glycoprotein IIb/IIIa inhibition

PMID: 15536101
DOI: 10.1001/jama.292.18.2211-b

Comment

Glycoprotein IIb/IIIa inhibition

Joel Klein. JAMA. 2004.

. 2004 Nov 10;292(18):2211; author reply 2211-2.

doi: 10.1001/jama.292.18.2211-b.

Author

PMID: 15536101
DOI: 10.1001/jama.292.18.2211-b

No abstract available

PubMed Disclaimer

Comment on

Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.
Montalescot G, Borentain M, Payot L, Collet JP, Thomas D. Montalescot G, et al. JAMA. 2004 Jul 21;292(3):362-6. doi: 10.1001/jama.292.3.362. JAMA. 2004. PMID: 15265852

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information